Developer docs
API playgroundTry for free, no card

Search company profiles

Elea

Full company profile

uuid0000k8b

Namestring
Elea
Legal namestring
Elea.ai GmbH
Websiteurl
elea.health
Company typeenum
Private
Founded yearint
2024
Descriptiontext

Elea (Elea.ai GmbH) is a privately-held German healthcare AI company that builds AI-native clinical information systems, with two core products: elea Lab, a Pathology Operating System (LIS) that orchestrates the end-to-end pathology workflow from digital order entry and accessioning through grossing, staining, reporting, and billing, and elea ED, a mobile Information System for hospital emergency departments providing AI-powered speech-to-structure documentation and team coordination. The platform is architected around conversational AI, voice recognition, deep hardware integration (cassette/slide printers, staining machines, scanners via HL7 and FHIR), and an embedded agentic AI that generates structured, codeable reports in real time, with the proprietary pathology AI trained on 500,000+ cases.

The company is headquartered in Hamburg, Germany with operational offices in Freiburg and San Francisco, and is KV-certified in Germany and GDPR-compliant by design. Its go-to-market is sales-led, direct enterprise SaaS with quote-based pricing, anchored on a small set of named reference customers in Germany (Osnabrück, Gesundheit Nord, PATHORA, Dessau, Bremen) and a rapidly expanding U.S. footprint via a strategic Lumea partnership and anchor accounts including OnePath Diagnostics (largest North American customer) and GastroMed Miami. Revenue is generated primarily through recurring subscriptions for elea Lab and elea ED, supplemented by implementation, onboarding, and training professional services bundled with customer rollouts.

Elea is led by four co-founders (CEO Dr. Christoph Schröder, CMO Dr. Sebastian Casu, COO Stephan Frank, CTO Tobias Lygren) supported by a Head of Growth (Carlo Sirna, joined January 2026) and Chief of Staff. The company raised approximately $8.98M in a March 2025 round led by Fly Ventures and Giant Ventures, and is actively hiring across product, engineering, and commercial functions. No revenue, customer count, or headcount figures are publicly disclosed, and the company does not yet report ARR, GMV, or profitability metrics.

Short descriptiontext

Elea builds AI-native healthcare information systems (elea Lab pathology LIS and elea ED emergency department platform) using voice-driven AI, agentic workflows, and deep hardware integration to automate clinical workflows for pathology labs, hospital systems, and multi-site networks in Germany and the United States.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersHamburg, Germany
HQ citystring
Hamburg
HQ countrystring
Germany
HQ regionstring
Europe
Markets served

Serves global market

Offices3 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
pathology operating system, clinical speech recognition, lab workflow automation, emergency department software, healthcare interoperability
Industry3 codes
PRIMARYHLACAOAA
Electronic Data Capture (EDC) Platforms
Healthcare & Life Sciences/Digital Health & Health IT/Clinical Trials & Research Informatics (eCOA/ePRO/EDC)
SECONDARYHLACABAC
Enterprise Integration Engines & Interface Management (HL7 v2/X12/API)
Healthcare & Life Sciences/Digital Health & Health IT/Health Information Exchange (HIE) & Interoperability
SECONDARYBPAEAHAB
Data Engineering, Integration & ETL/ELT Services
NAICS code3 codes
  • Software Publishers513210
  • Software Publishers5132
  • Custom Computer Programming Services541511
SIC code2 codes
  • Services-Computer Programming, Data Processing, Etc.7370
  • Services-Computer Processing & Data Preparation7374
Product category
Pathology Software
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model3 records
1Healthcare SaaS Subscription (elea Lab)
TypeSubscription Recurring
Description

Recurring software subscription revenue from elea Lab (AI-native Pathology Operating System), sold to pathology labs, hospital systems, and multi-site pathology networks. Pricing is not publicly disclosed — quote-based enterprise deals. Scales across small labs to large nationwide networks.

elea.health
2Healthcare SaaS Subscription (elea ED)
TypeSubscription Recurring
Description

Recurring subscription revenue from elea ED, the AI-powered Emergency Department Information System. Targets hospital EDs and emergency care teams; pricing not publicly disclosed.

elea.health
3Implementation, Onboarding & Training Services
TypeProfessional Services
Description

Professional services for onboarding, role-based training, interoperability integration with existing IT systems, and ongoing partnership-based support. Included as part of customer rollout.

elea.health
Marketing channels9 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Technology or R&D, Personnel, Operations, Marketing or Sales, Infrastructure
Pricing details1 tier
1Quote-based enterprise pricing for elea Lab and elea ED
ModelOther
Notes

Pricing not publicly disclosed; quote-based via demo request. Available plans not enumerated on website. KV-certified in Germany enables statutory billing integration.

elea.health
GTM typeB2B
B2B
Offering typeSoftware
Software
Brand1 of 2 records shown
1elea Lab
Description

AI-powered Pathology Operating System (LIS) that orchestrates the end-to-end pathology laboratory workflow, including accessioning, lab processing, slide tracking, reporting, and case sign-out.

elea.health
+1 more record
Core offering1 text field

Elea sells AI-powered healthcare information systems, primarily elea Lab (an AI-native Pathology Operating System that orchestrates the end-to-end pathology workflow from accession through final report) and elea ED (an AI-powered Emergency Department Information System for real-time clinical documentation). The platform replaces fragmented legacy LIS, dictation, and reporting stacks with a single conversational AI system that captures voice input, generates structured reports, controls lab hardware, and integrates with hospital systems via HL7 and FHIR standards.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 7 values shown
  • 85+% review & approval completed in under 30 seconds
+6 more records
Product overview1 text field

Elea offers a platform-plus-modules architecture of AI-powered healthcare information systems centered on two core products: elea Lab, the AI-native Pathology Operating System that orchestrates the entire pathology workflow from accession through final report, and elea ED, the AI-powered Emergency Department Information System for real-time clinical documentation and team coordination. Both products share elea's AI-native foundation — built on conversational AI, voice recognition, deep hardware integration, and an embedded agentic AI that runs continuously across clinical workflows — and connect to external partners via HL7/FHIR-based interoperability with image management systems, scanners, and laboratory devices.

Product and service2 records
1elea Lab
CategoryPathology Operating System / Laboratory Information System
Description

AI-native Pathology Operating System that unifies lab hardware and data, automates documentation, and connects partner labs and hospitals in one platform. Supports the full end-to-end pathology workflow from digital order entry through macroscopic examination, complete laboratory process, histological assessment, report creation, and report delivery, with a Pathology AI trained on 500,000+ cases.

2elea ED
CategoryEmergency Department Information System
Description

Mobile AI-powered Information System for Emergency Departments that simplifies every workflow end-to-end and improves documentation accuracy. Provides AI-powered speech-to-structure documentation, clinical workflow coordination, standard operating procedures, handover summaries, inter-role communication, and resource/capacity management via live dashboards.

Scale indicator8 records

Each record includes

Type, Value, Description, Source

Partnership5 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-05-27
Description

GastroMed becomes elea's first laboratory partner in Florida, marking a targeted step in elea's U.S. expansion. GastroMed implements elea Lab to consolidate accession, lab processes, dictation, and reporting into a single end-to-end environment for gastrointestinal pathology. The deployment spans 7 practice locations and 4 endoscopy centers with 15 board-certified gastroenterologists.

2OnePath Diagnostics
Strategic tierFlagshipTypeStrategic or Co-development PartnerAnnounced on2026-05-08
Description

Strategic partnership deploying elea's Pathology Operating System as the central platform orchestrating workflow across OnePath's nationwide sub-specialty network. OnePath is one of the largest pathology groups in the U.S., headquartered in Jacksonville, FL, and the deployment makes OnePath elea's largest customer in North America. Integration underway across central operations at the time of announcement.

elea.health
Strategic tierMinorTypeImplementation/ SI/ Consulting PartnerAnnounced on2026-04-01
Description

Elea worked with Ignis Design Agency to design and develop the relaunched elea.health website (launched April 2026).

Strategic tierFlagshipTypeStrategic or Co-development PartnerAnnounced on2026-03-17
Description

Strategic partnership combining Lumea's FDA-cleared IMS Viewer+ with elea's AI-native agentic LIS to create a unified pathology ecosystem. Targets the U.S. market with a 'one-screen, one-workspace' experience enabling voice-driven AI navigation and zero manual data re-entry. Lumea is elea's preferred digital pathology partner for its U.S. launch; both companies co-showcased the unified ecosystem at USCAP 2026 in San Antonio (March 21–26, 2026).

5PATHORA (Sven Perner)
Strategic tierMinorTypeOthersAnnounced on2026-03-17
Description

Elea sponsored and exhibited at the 2nd PATHORA Symposium on Bladder Cancer in Reutlingen following the invitation of Prof. Dr. med. Sven Perner. PATHORA customers (Professors and Specialists in Pathology) also provide testimonials for elea Lab.

elea.health
Recent move9 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

AI pathology company developing diagnostic and drug-development tools for pathology. Overlaps with Elea in bringing AI into routine pathology lab workflows and is a direct competitor for AI-driven pathology budgets at large hospital systems and pharma.

TypeDirect peer
Description

AI-powered cancer diagnostics platform for pathology, deployed in clinical workflows at hospital and reference labs. Closely comparable in applying AI to routine pathology case review and quality assurance, and a credible alternative for labs evaluating AI-native workflow tools.

TypeBroad incumbent
Description

AI-powered diagnostic imaging and population-health platform, now part of RadNet, that applies AI to clinical imaging workflows. Comparable in bringing AI into clinical diagnostic workflows and in targeting hospital/health-system buyers, though primarily in radiology rather than pathology.

TypeBroad incumbent
Description

Major European healthcare IT vendor offering laboratory and diagnostic information systems across multiple countries including Germany. Comparable to Elea on the LIS side and to Elea's home German market, but as a broad incumbent with multi-decade hospital relationships rather than an AI-native challenger.

TypeOthers
Description

FDA-cleared digital pathology IMS viewer provider that is Elea's preferred U.S. distribution partner. Lumea's image-management system complements Elea's LIS, and the two companies have a flagship co-marketed 'one-screen, one-workspace' ecosystem, making Lumea the most direct channel partner rather than a direct competitor.

TypeDirect peer
Description

Provider of AI-powered digital pathology image-analysis software deployed in clinical and research labs. Comparable to Elea as a software-led pathology AI vendor selling into hospital and reference-lab customers, although Indica is more focused on image analysis and pharma research workflows.

TypeDirect peer
Description

AI-native digital pathology company offering AI-powered cancer detection and diagnostics tools for pathology labs. Directly comparable to Elea in applying AI to pathology workflows, although Paige focuses more on image-based AI whereas Elea's edge is workflow/LIS orchestration and voice-driven structured reporting.

TypeDirect peer
Description

Digital pathology platform provider offering an AI-enabled enterprise pathology platform for diagnostic workflows and image management. Directly comparable to Elea's pathology-focused software play, with a similar enterprise SaaS GTM motion to hospital and reference labs.

TypeBroad incumbent
Description

Large established provider of digital pathology and LIS solutions to hospitals across Europe and the US. Comparable as a competing LIS/digital pathology incumbent that Elea must displace in enterprise procurements, but offers AI capabilities as part of a much broader imaging-IT portfolio.

TypeEmerging player
Description

Germany-based AI-powered structured reporting vendor for radiology and pathology. Closely comparable to Elea's automated, AI-generated structured-reporting value proposition and to Elea's home German market, with overlapping customer personas in hospital diagnostic departments.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat7 records

Each record includes

Type, Details

Key risks7 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers8 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment6 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

Integration2 records

Each record includes

Title, Type, Description, Source

AI capability8 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature12 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles6 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance2 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds1 record

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors2 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Elea

Pathology Softwareelea.health

Elea builds AI-native healthcare information systems (elea Lab pathology LIS and elea ED emergency department platform) using voice-driven AI, agentic workflows, and deep hardware integration to automate clinical workflows for pathology labs, hospital systems, and multi-site networks in Germany and the United States.

What Elea does

Elea (Elea.ai GmbH) is a privately-held German healthcare AI company that builds AI-native clinical information systems, with two core products: elea Lab, a Pathology Operating System (LIS) that orchestrates the end-to-end pathology workflow from digital order entry and accessioning through grossing, staining, reporting, and billing, and elea ED, a mobile Information System for hospital emergency departments providing AI-powered speech-to-structure documentation and team coordination. The platform is architected around conversational AI, voice recognition, deep hardware integration (cassette/slide printers, staining machines, scanners via HL7 and FHIR), and an embedded agentic AI that generates structured, codeable reports in real time, with the proprietary pathology AI trained on 500,000+ cases.

The company is headquartered in Hamburg, Germany with operational offices in Freiburg and San Francisco, and is KV-certified in Germany and GDPR-compliant by design. Its go-to-market is sales-led, direct enterprise SaaS with quote-based pricing, anchored on a small set of named reference customers in Germany (Osnabrück, Gesundheit Nord, PATHORA, Dessau, Bremen) and a rapidly expanding U.S. footprint via a strategic Lumea partnership and anchor accounts including OnePath Diagnostics (largest North American customer) and GastroMed Miami. Revenue is generated primarily through recurring subscriptions for elea Lab and elea ED, supplemented by implementation, onboarding, and training professional services bundled with customer rollouts.

Elea is led by four co-founders (CEO Dr. Christoph Schröder, CMO Dr. Sebastian Casu, COO Stephan Frank, CTO Tobias Lygren) supported by a Head of Growth (Carlo Sirna, joined January 2026) and Chief of Staff. The company raised approximately $8.98M in a March 2025 round led by Fly Ventures and Giant Ventures, and is actively hiring across product, engineering, and commercial functions. No revenue, customer count, or headcount figures are publicly disclosed, and the company does not yet report ARR, GMV, or profitability metrics.

Elea firmographics

Firmographics
Name
Elea
Legal name
Elea.ai GmbH
Website
https://elea.health
Company type
Private
Founded year
2024
Operating status
Operating
Headcount range
11–50 employees
Short description
Elea builds AI-native healthcare information systems (elea Lab pathology LIS and elea ED emergency department platform) using voice-driven AI, agentic workflows, and deep hardware integration to automate clinical workflows for pathology labs, hospital systems, and multi-site networks in Germany and the United States.
Ownership category
akta.pro rank

Elea industry classification

Industry
Product category
Pathology Software
NAICS
Software Publishers (513210), Software Publishers (5132), Custom Computer Programming Services (541511)
SIC
Services-Computer Programming, Data Processing, Etc. (7370), Services-Computer Processing & Data Preparation (7374)
akta.pro industry
PRIMARYHLACAOAA
Electronic Data Capture (EDC) Platforms
Healthcare & Life Sciences/Digital Health & Health IT/Clinical Trials & Research Informatics (eCOA/ePRO/EDC)
SECONDARYHLACABAC
Enterprise Integration Engines & Interface Management (HL7 v2/X12/API)
Healthcare & Life Sciences/Digital Health & Health IT/Health Information Exchange (HIE) & Interoperability
SECONDARYBPAEAHAB
Data Engineering, Integration & ETL/ELT Services

Keywords

  • Pathology operating system
  • Clinical speech recognition
  • Lab workflow automation
  • Emergency department software
  • Healthcare interoperability

Where Elea is headquartered

Location

Headquarters

HQ city
Hamburg
HQ country
Germany
HQ region
Europe

Offices3 records

Markets served

Elea business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Technology or R&D, Personnel, Operations, Marketing or Sales, Infrastructure

Revenue model

  1. Healthcare SaaS Subscription (elea Lab): Recurring software subscription revenue from elea Lab (AI-native Pathology Operating System), sold to pathology labs, hospital systems, and multi-site pathology networks. Pricing is not publicly disclosed — quote-based enterprise deals. Scales across small labs to large nationwide networks.
  2. Healthcare SaaS Subscription (elea ED): Recurring subscription revenue from elea ED, the AI-powered Emergency Department Information System. Targets hospital EDs and emergency care teams; pricing not publicly disclosed.
  3. Implementation, Onboarding & Training Services: Professional services for onboarding, role-based training, interoperability integration with existing IT systems, and ongoing partnership-based support. Included as part of customer rollout.

Pricing tiers

ModelBillingPrice
Other—Quote-based enterprise pricing for elea Lab and elea ED

Go-to-market motion1 record

Distribution channels4 records

Marketing channels9 records

Elea product offering

Product offering

Core offering

Elea sells AI-powered healthcare information systems, primarily elea Lab (an AI-native Pathology Operating System that orchestrates the end-to-end pathology workflow from accession through final report) and elea ED (an AI-powered Emergency Department Information System for real-time clinical documentation). The platform replaces fragmented legacy LIS, dictation, and reporting stacks with a single conversational AI system that captures voice input, generates structured reports, controls lab hardware, and integrates with hospital systems via HL7 and FHIR standards.

Product overview

Elea offers a platform-plus-modules architecture of AI-powered healthcare information systems centered on two core products: elea Lab, the AI-native Pathology Operating System that orchestrates the entire pathology workflow from accession through final report, and elea ED, the AI-powered Emergency Department Information System for real-time clinical documentation and team coordination. Both products share elea's AI-native foundation — built on conversational AI, voice recognition, deep hardware integration, and an embedded agentic AI that runs continuously across clinical workflows — and connect to external partners via HL7/FHIR-based interoperability with image management systems, scanners, and laboratory devices.

Differentiator

Problem solved

Functional benefit

Brands

  • elea Lab: AI-powered Pathology Operating System (LIS) that orchestrates the end-to-end pathology laboratory workflow, including accessioning, lab processing, slide tracking, reporting, and case sign-out.
  • elea ED

Products and services

  • elea Lab AI-native Pathology Operating System that unifies lab hardware and data, automates documentation, and connects partner labs and hospitals in one platform. Supports the full end-to-end pathology workflow from digital order entry through macroscopic examination, complete laboratory process, histological assessment, report creation, and report delivery, with a Pathology AI trained on 500,000+ cases.
  • elea ED Mobile AI-powered Information System for Emergency Departments that simplifies every workflow end-to-end and improves documentation accuracy. Provides AI-powered speech-to-structure documentation, clinical workflow coordination, standard operating procedures, handover summaries, inter-role communication, and resource/capacity management via live dashboards.

Quantifiable outcome

  • 85+% review & approval completed in under 30 seconds
  • +6 more outcomes

Companies that use Elea

Customer profile

Named customers8 records

Segments6 records

Ideal customer profiles3 records

Elea technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration2 records

AI capability8 records

Feature12 records

Elea partnerships and signals

Strategic signal

Partnerships

Five partnerships are on record, tiered core, flagship and minor.

  • GastroMed (Miami)coreStrategic or Co-development Partner · 27 May 2026GastroMed becomes elea's first laboratory partner in Florida, marking a targeted step in elea's U.S. expansion. GastroMed implements elea Lab to consolidate accession, lab processes, dictation, and reporting into a single end-to-end environment for gastrointestinal pathology. The deployment spans 7 practice locations and 4 endoscopy centers with 15 board-certified gastroenterologists.
  • OnePath DiagnosticsflagshipStrategic or Co-development Partner · 8 May 2026Strategic partnership deploying elea's Pathology Operating System as the central platform orchestrating workflow across OnePath's nationwide sub-specialty network. OnePath is one of the largest pathology groups in the U.S., headquartered in Jacksonville, FL, and the deployment makes OnePath elea's largest customer in North America. Integration underway across central operations at the time of announcement.
  • Ignis Labs (Ignis Design Agency)minorImplementation/ SI/ Consulting Partner · 1 April 2026Elea worked with Ignis Design Agency to design and develop the relaunched elea.health website (launched April 2026).
  • LumeaflagshipStrategic or Co-development Partner · 17 March 2026Strategic partnership combining Lumea's FDA-cleared IMS Viewer+ with elea's AI-native agentic LIS to create a unified pathology ecosystem. Targets the U.S. market with a 'one-screen, one-workspace' experience enabling voice-driven AI navigation and zero manual data re-entry. Lumea is elea's preferred digital pathology partner for its U.S. launch; both companies co-showcased the unified ecosystem at USCAP 2026 in San Antonio (March 21–26, 2026).
  • PATHORA (Sven Perner)minorOthers · 17 March 2026Elea sponsored and exhibited at the 2nd PATHORA Symposium on Bladder Cancer in Reutlingen following the invitation of Prof. Dr. med. Sven Perner. PATHORA customers (Professors and Specialists in Pathology) also provide testimonials for elea Lab.

Scale indicators8 records

Recent moves9 records

Expansion highlights6 records

Elea competitors and assessment

Company assessment

Direct peers

  • PathAI: AI pathology company developing diagnostic and drug-development tools for pathology. Overlaps with Elea in bringing AI into routine pathology lab workflows and is a direct competitor for AI-driven pathology budgets at large hospital systems and pharma.
  • Ibex Medical Analytics: AI-powered cancer diagnostics platform for pathology, deployed in clinical workflows at hospital and reference labs. Closely comparable in applying AI to routine pathology case review and quality assurance, and a credible alternative for labs evaluating AI-native workflow tools.
  • Indica Labs: Provider of AI-powered digital pathology image-analysis software deployed in clinical and research labs. Comparable to Elea as a software-led pathology AI vendor selling into hospital and reference-lab customers, although Indica is more focused on image analysis and pharma research workflows.
  • Paige.AI: AI-native digital pathology company offering AI-powered cancer detection and diagnostics tools for pathology labs. Directly comparable to Elea in applying AI to pathology workflows, although Paige focuses more on image-based AI whereas Elea's edge is workflow/LIS orchestration and voice-driven structured reporting.
  • Proscia: Digital pathology platform provider offering an AI-enabled enterprise pathology platform for diagnostic workflows and image management. Directly comparable to Elea's pathology-focused software play, with a similar enterprise SaaS GTM motion to hospital and reference labs.

Broad incumbents

  • DeepHealth (by RadNet): AI-powered diagnostic imaging and population-health platform, now part of RadNet, that applies AI to clinical imaging workflows. Comparable in bringing AI into clinical diagnostic workflows and in targeting hospital/health-system buyers, though primarily in radiology rather than pathology.
  • Dedalus Group: Major European healthcare IT vendor offering laboratory and diagnostic information systems across multiple countries including Germany. Comparable to Elea on the LIS side and to Elea's home German market, but as a broad incumbent with multi-decade hospital relationships rather than an AI-native challenger.
  • Sectra: Large established provider of digital pathology and LIS solutions to hospitals across Europe and the US. Comparable as a competing LIS/digital pathology incumbent that Elea must displace in enterprise procurements, but offers AI capabilities as part of a much broader imaging-IT portfolio.

Others

  • Lumea: FDA-cleared digital pathology IMS viewer provider that is Elea's preferred U.S. distribution partner. Lumea's image-management system complements Elea's LIS, and the two companies have a flagship co-marketed 'one-screen, one-workspace' ecosystem, making Lumea the most direct channel partner rather than a direct competitor.

Emerging players

  • Smart Reporting: Germany-based AI-powered structured reporting vendor for radiology and pathology. Closely comparable to Elea's automated, AI-generated structured-reporting value proposition and to Elea's home German market, with overlapping customer personas in hospital diagnostic departments.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat7 records

Key risks7 records

Key highlights7 records

Customer concentration

Elea social profiles

Digital presence

Elea compliance and trust

Trust signal

Compliance2 records

Elea financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Elea leadership team

Management profile

Number of profiles

Profiles6 records

Elea funding detail

Funding detail

Funding overview

Funding rounds1 record

Investors2 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Elea M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Elea

What does Elea do?

Elea sells AI-powered healthcare information systems, primarily elea Lab (an AI-native Pathology Operating System that orchestrates the end-to-end pathology workflow from accession through final report) and elea ED (an AI-powered Emergency Department Information System for real-time clinical documentation). The platform replaces fragmented legacy LIS, dictation, and reporting stacks with a single conversational AI system that captures voice input, generates structured reports, controls lab hardware, and integrates with hospital systems via HL7 and FHIR standards.

Is Elea a public or private company?

Elea is a private company. It is classified as venture growth investor backed and is currently operating.

When was Elea founded?

Elea was founded in 2024. It employs 11 to 50 people.

Where is Elea based?

Elea is headquartered in Hamburg, Germany, in the Europe region.

How does Elea make money?

Three revenue lines are on record. Healthcare SaaS Subscription (elea Lab) is the primary driver. The others are healthcare SaaS Subscription (elea ED) and implementation, Onboarding & Training Services.

Who are Elea's main competitors?

Direct peers on record are PathAI, Ibex Medical Analytics, Indica Labs, Paige.AI and Proscia. Broad incumbents are DeepHealth (by RadNet), Dedalus Group and Sectra. Lumea is listed as an others. Smart Reporting is listed as an emerging player.

Does Elea have an API?

No public API is recorded for Elea.

What industry is Elea in?

Elea's product category is Pathology Software. Its primary akta.pro industry code is HLACAOAA, Electronic Data Capture (EDC) Platforms, with a secondary code of HLACABAC, Enterprise Integration Engines & Interface Management (HL7 v2/X12/API). Its NAICS code is 513210 and its SIC code is 7370.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
EIN PresswireTechcyte and elea Bring AI-Native Pathology Reporting into Techcyte FusionⓇTechcyte and elea announced that eleaDNAi, an AI-native pathology reporting tool, is now available within Techcyte Fusion. The partnership lets pathologists generate structured, coded reports via voice or click, with interoperability for downstream systems. elea aims to expand its core reporting intelligence beyond its own LIS into third-party platforms.EIN PresswireOnePath Diagnostics picks elea's AI-native Pathology Operating System to orchestrate its nationwide networkOnePath Diagnostics and elea announced a partnership deploying elea's AI-native Pathology Operating System across OnePath's nationwide sub-specialty network. The system will orchestrate lab workflows while pathologists continue using their existing image-management system. Integration is underway, with rollout expected to complete within coming weeks.LAVCAVictoria Capital Partners Exits Cellera Farma Via Sale to EleaVictoria Capital Partners exited Cellera Farma through a strategic sale to Elea, one of Argentina's largest pharmaceutical companies. The deal was announced on 4 June 2026. No further details on the transaction were disclosed.EIN Presswireelea establishes AI-native Pathology Operating System in Florida with first laboratory at GastroMed Miamielea announced a partnership with GastroMed Miami, making GastroMed its first U.S. laboratory partner. The collaboration implements elea Lab, an AI-native pathology operating system that generates structured reports in real time, replacing fragmented legacy systems. The partnership aims to validate improvements in turnaround time and data usability.PR NewswireEurope Laboratory Information System (LIS) Market to Surpass USD 689.05 Million by 2031 - Exclusive Insights by AriztonThe Europe laboratory information systems market is projected to reach USD 689.05 million by 2031, growing at a 7.28% CAGR from USD 452.08 million in 2025. Germany leads with a 23% share, and the integrated LIS segment holds about 68% of the market. Cloud-based hosting is expected to grow fastest at an 8.69% CAGR.AInvestThe AI Revolution in Healthcare: Strategic Partnerships Reshaping Cost Structures and Investment OpportunitiesThe global AI healthcare market is projected to grow from $26.57 billion in 2024 to $187.69 billion by 2030, driven by partnerships like Microsoft's Dragon Copilot and Elea's diagnostic platform. These alliances cut documentation time by up to 69.5% and diagnostic timelines by 90%, while regulatory-ready solutions like Nuance's AI scribe address compliance costs.Pulse 2.0elea: €4 Million Raised For AI-Based Healthcare Platformelea raised €4 million from Fly Ventures and Giant Ventures and announced a partnership with a major German hospital group. The AI platform cut pathology diagnosis time from 2-3 weeks to hours, and will scale department-by-department starting with pathology.FinSMEselea Raises €4M in Fundingelea, a Hamburg-based healthcare AI platform, raised €4M from Fly Ventures, Giant Ventures, and MVZ hospital groups. The funds will scale the platform, widen reach, and expand into new departments. One German hospital group uses elea to process 70,000+ cases annually.N24Elea Secures €4M to Scale AI-Based Healthcare Operations Across Ger…Elea, a Hamburg-based healthtech startup, has raised €4 million in funding from Fly Ventures and Giant Ventures to expand its AI-powered healthcare platform across German hospital departments. The company announced a partnership with one of Germany’s largest MVZ hospital groups to support clinicians by automating administrative tasks and improving diagnostics.